Global X Morningstar Global Technology ETF (TECH) Stock Price, News & Analysis

Company Overview

Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 5,275 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TECH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Global X Morningstar Global Technology ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global X Morningstar Global Technology ETF investors own include Barrick Gold (GOLD), AC Immune (ACIU), Achieve Life Sciences (ACHV), Acer Therapeutics (ACER), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Manufacturing
• Industry: Biological Product (Except Diagnostic) Manufacturing
• Sub-Industry: N/A
• Current Symbol: ASX:TECH
• CUSIP: N/A
• CIK: N/A
• Web: www.bio-techne.com
• Phone: 16123798854
• Fax: N/A
• Employees: 2,300
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A